These improvements in histomorphometric measures of left ventricular structural remodeling observed after treatment with elamipretide are similar in magnitude to those seen in this canine heart failure model after monotherapy with ACE inhibitors, angiotensin II receptor blockers, and beta-blockers [65–68] and are not likely to immediately subside if elamipretide therapy is withdrawn. The gene discussed is ACE; the disease is heart failure.